JP2014518240A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518240A5
JP2014518240A5 JP2014517749A JP2014517749A JP2014518240A5 JP 2014518240 A5 JP2014518240 A5 JP 2014518240A5 JP 2014517749 A JP2014517749 A JP 2014517749A JP 2014517749 A JP2014517749 A JP 2014517749A JP 2014518240 A5 JP2014518240 A5 JP 2014518240A5
Authority
JP
Japan
Prior art keywords
structural formula
compound
thiadiazole
piperazine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014517749A
Other languages
English (en)
Japanese (ja)
Other versions
JP5972367B2 (ja
JP2014518240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/062778 external-priority patent/WO2013004642A1/en
Publication of JP2014518240A publication Critical patent/JP2014518240A/ja
Publication of JP2014518240A5 publication Critical patent/JP2014518240A5/ja
Application granted granted Critical
Publication of JP5972367B2 publication Critical patent/JP5972367B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014517749A 2011-07-01 2012-06-29 神経変性疾患の治療に有用な1,2,4−チアジアゾール−5−イルピペラジン誘導体 Expired - Fee Related JP5972367B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11172324.3 2011-07-01
EP11172324 2011-07-01
PCT/EP2012/062778 WO2013004642A1 (en) 2011-07-01 2012-06-29 1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2014518240A JP2014518240A (ja) 2014-07-28
JP2014518240A5 true JP2014518240A5 (https=) 2015-05-28
JP5972367B2 JP5972367B2 (ja) 2016-08-17

Family

ID=46545347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014517749A Expired - Fee Related JP5972367B2 (ja) 2011-07-01 2012-06-29 神経変性疾患の治療に有用な1,2,4−チアジアゾール−5−イルピペラジン誘導体

Country Status (9)

Country Link
US (1) US9023852B2 (https=)
EP (1) EP2726470B1 (https=)
JP (1) JP5972367B2 (https=)
CN (1) CN103619825B (https=)
AU (1) AU2012280420B2 (https=)
CA (1) CA2837247C (https=)
ES (1) ES2540956T3 (https=)
PL (1) PL2726470T3 (https=)
WO (1) WO2013004642A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9187440B2 (en) * 2011-08-17 2015-11-17 Remynd Nv Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
WO2015140130A1 (en) * 2014-03-17 2015-09-24 Remynd Nv Oxadiazole compounds
SG11201811023UA (en) 2016-06-23 2019-01-30 St Jude Childrens Res Hospital Small molecule modulators of pantothenate kinases
JP2019533022A (ja) * 2016-10-24 2019-11-14 ユマニティ セラピューティクス,インコーポレーテッド 化合物及びその使用
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2019133635A1 (en) 2017-12-27 2019-07-04 St. Jude Children's Research Hospital Small molecule modulators of pantothenate kinases
JP7527967B2 (ja) 2017-12-27 2024-08-05 セント ジュード チルドレンズ リサーチ ホスピタル,インコーポレイティド Castorに関連する障害を治療する方法
WO2019183587A1 (en) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2020154571A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
WO2025104092A1 (en) 2023-11-13 2025-05-22 Remynd N.V. Modulators of septin 6 for use in the prevention and/or treatment of neurodegenerative disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2361179A1 (en) * 1999-03-03 2000-09-08 American Home Products Corporation New diazole derivatives as serotonergic agents
DE60003911T2 (de) * 1999-04-26 2004-05-27 Neurosearch A/S Heteroaryl-diazacycloalkane, ihre herstellung und verwendung
DE102004032567A1 (de) * 2004-07-05 2006-03-02 Grünenthal GmbH Substituierte 1-Propiolyl-piperazine
US7541359B2 (en) * 2005-06-30 2009-06-02 Janssen Pharmaceutica N.V. N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
WO2007092435A2 (en) * 2006-02-07 2007-08-16 Wyeth 11-beta hsd1 inhibitors
GB0602335D0 (en) * 2006-02-07 2006-03-15 Remynd Nv Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases

Similar Documents

Publication Publication Date Title
JP2014518240A5 (https=)
Havrylyuk et al. Synthesis of pyrazoline–thiazolidinone hybrids with trypanocidal activity
JP2010516681A5 (https=)
JP2009533369A5 (https=)
JP2016512822A5 (https=)
JP2018528182A5 (https=)
BG65029B1 (bg) Триазолови съединения и използването им като допамин-d3-лиганди
EP2906554A1 (en) Solid forms of nilotinib hydrochloride
JP2015522037A (ja) ベムラフェニブコリン塩の固体形態
JP2020512400A5 (https=)
RU2717830C2 (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
JP2011105685A (ja) フェネチルアミン化合物の結晶
CN102295655A (zh) 一种氧头孢烯类抗菌素中间体溶剂化物及其制备方法
US3509153A (en) 5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles
Boland et al. Routes to novel mono-and bis-tetrazole compounds: synthesis, spectroscopic and structural characterization
JP2005263673A (ja) 5−保護アミノピリミジン化合物の製造方法
EP2941420B1 (en) (4e)-4-(4-substituted benzylideneamino)-2,3-dihydro-3- substituted-2-thioxothiazole-5-carbonitriles as a2ar antagonist and process for preparation thereof
CN102229578B (zh) 一种2-芳胺基-1,3,4-噁二唑化合物的制备方法
JP5004643B2 (ja) N−(2−アミノ−1,2−ジシアノビニル)ホルムアミジンの製造方法
KR102702677B1 (ko) 피마살탄 및 그의 제조 중간체의 제조방법
IL291569B1 (en) Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine
JP2017514845A5 (https=)
CN103880750A (zh) 一种替格列汀关键中间体的制备方法
Fathalla Syntheses and reactions of methyl [3-(4-phenyl-thiazol-2-yl)-thioureido] alkanoates and related compounds
CN105037331B (zh) 瑞舒伐他汀中间体的制备方法